Technical Analysis for CORV - Correvio Pharma Corp

Grade Last Price % Change Price Change
grade F 3.37 -0.88% -0.030
CORV closed down 0.88 percent on Tuesday, May 21, 2019, on 34 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical CORV trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Wide Range Bar Range Expansion 0.00%
BB Squeeze + Upper Band Touch Range Contraction 0.00%
Outside Day Range Expansion 0.00%
Upper Bollinger Band Touch Strength 0.00%
Down 3 Days in a Row Weakness 0.00%
20 DMA Resistance Bearish -0.88%
Bollinger Band Squeeze Range Contraction -0.88%
Fell Below 20 DMA Bearish -5.07%

Older signals for CORV ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Correvio Pharma Corp is a Canada-based specialty pharmaceutical company. It provides brands that meet the needs of acute care physicians and patients. It develops, acquires and commercializes brands for the in-hospital, acute care market segment. The following is its portfolio of approved and marketed brands: Xydalba, for the treatment of acute bacterial skin and skin structure infections (ABSSSI); Zevtera/Mabelio, a cephalosporin antibiotic for the treatment of community-acquired pneumonia (CAP) and hospital-acquired pneumonia (HAP); Brinavess for the conversion of recent onset atrial fibrillation to sinus rhythm; Aggrastat for the reduction of thrombotic cardiovascular events in patients with acute coronary syndrome, as well as Esmocard and Esmocard Lyo, a short-acting betablocker used to control rapid heart rate in a number of cardiovascular indications. Its pipeline of product candidates includes Trevyent, a drug device combination that is designed to deliver treprostinil.
Medicine Health RTT Pharmaceutical Infectious Diseases Acute Coronary Syndrome Tirofiban
Is CORV a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 6.9
52 Week Low 2.65
Average Volume 18,106
200-Day Moving Average 4.5747
50-Day Moving Average 3.975
20-Day Moving Average 3.5345
10-Day Moving Average 3.591
Average True Range 0.2557
ADX 24.8
+DI 23.0425
-DI 19.7216
Chandelier Exit (Long, 3 ATRs ) 3.1729
Chandelier Exit (Short, 3 ATRs ) 3.9071
Upper Bollinger Band 3.8633
Lower Bollinger Band 3.2057
Percent B (%b) 0.25
BandWidth 18.605178
MACD Line -0.1154
MACD Signal Line -0.1212
MACD Histogram 0.0059
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.270
Resistance 3 (R3) 4.343 4.117 4.120
Resistance 2 (R2) 4.117 3.887 4.080 4.070
Resistance 1 (R1) 3.743 3.746 3.630 3.670 4.020
Pivot Point 3.517 3.517 3.460 3.480 3.517
Support 1 (S1) 3.143 3.287 3.030 3.070 2.720
Support 2 (S2) 2.917 3.146 2.880 2.670
Support 3 (S3) 2.543 2.917 2.620
Support 4 (S4) 2.470